Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Products In Brief

This article was originally published in The Tan Sheet

Executive Summary

Diabetes supplement: Diabco Life Sciences launches nutraceutical with natural ingredients that have been "clinically documented and scientifically reported to help lower blood glucose levels," Carmel, Ind.-based firm says. Diabatrol is a "nutrient-dense, fiber and antioxidant-rich dietary supplement that has been scientifically proven to stabilize blood sugar spiking and reduce insulin resistance, two conditions that most often lead to Type II diabetes," the firm says. Diabatrol is a powder to be mixed with a low-sugar liquid, taken twice daily. A 60 packet one-month supply is sold online for $59.99, but the firm plans to bring the product into the retail channel soon. Ingredients include stabilized rice bran derivatives, rice protein concentrate, natural vanilla flavor, CMC gum, vitamins, mineral supplement, and aspartame...
Advertisement

Related Content

Natrol Pumps Up In Sports Nutrition Market With MRI Acquisition
Natrol Pumps Up In Sports Nutrition Market With MRI Acquisition

Topics

Advertisement
UsernamePublicRestriction

Register

PS100957

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel